样式: 排序: IF: - GO 导出 标记为已读
-
Managing vestibular schwannomas with radiosurgery and radiotherapy: AGREE II appraisal of clinical practice guidelines J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-13 Deepak Lakshmipathy, Eric Winter, Christian Fritz, Jacob Harris, Michelle Gentile, Alvaro Moreira, Karthik Rajasekaran
IntroductionVestibular schwannomas (VSs) are rare, benign intracranial tumours that have prompted clinical practice guideline (CPG) creation given their complex management. Our aim was to utilize the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument to assess if such CPGs on the management of VSs with radiosurgery and radiotherapy are of acceptable quality.MethodsRelevant CPGs
-
Hypofractionated radiation therapy combined with androgen deprivation therapy for high‐risk localized prostate cancer J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-13 Tae Hoon Lee, Hongryull Pyo, Gyu Sang Yoo, Seong Soo Jeon, Seong Il Seo, Byong Chang Jeong, Hwang Gyun Jeon, Hyun Hwan Sung, Minyong Kang, Wan Song, Jae Hoon Chung, Bong Kyung Bae, Won Park
IntroductionThis study aimed to analyse the treatment outcomes of moderately hypofractionated radiation therapy (RT) combined with androgen deprivation therapy (ADT) and the prognostic implications of prostate‐specific antigen (PSA) kinetics in high‐risk localized prostate cancer.MethodsThe medical records of 140 patients who underwent definitive RT (70 Gy in 28 fractions) combined with ADT were retrospectively
-
Percutaneous microwave ablation of T1a renal cell carcinomas: A 10‐year single‐center retrospective review J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-13 Cassie McCloskey, Angela Jacques, Dylan McCloskey, Jonathan Tibballs
IntroductionPartial nephrectomy is currently the preferred treatment option for T1a renal cell carcinomas (RCC), with nephron‐sparing techniques, including microwave ablation, becoming more common in select patients. Primary aims are to document outcomes of microwave ablation for T1a RCCs in an Australian tertiary centre to add to the evidence for its safety and efficacy.MethodsThe prospectively maintained
-
Thirty‐day mortality after palliative radiotherapy in advanced cancer patients: Optimizing end‐of‐life care in Asia J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-07 Mi Sun Kim, Hyejung Cha, Sei Hwan You, Sunghyun Kim
IntroductionEvidence‐based guidelines recommend hypofractionated palliative radiotherapy (PRT); nonetheless, many patients receive prolonged course of PRT. To identify patients with limited benefits from PRT in end‐of‐life care, we evaluated the pattern of PRT at an Asian institution and factors associated with 30‐day mortality after PRT (30dM).MethodsWe retrospectively reviewed 228 patients who died
-
Established advanced practice roles in radiation therapy: A scoping review J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-07 Sarah Lawlor, Michelle Leech
Advanced practitioners are healthcare professionals that are highly skilled with a particular area of expertise. These roles have been successfully implemented in many healthcare settings, improving efficiency of the service, as well as enhancing the standard of care received by patients. Although advanced practice roles have been implemented in some radiation therapy departments, their implementation
-
Are multiple projections necessary when assessing umbilical venous catheter placement in neonates? A retrospective study J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-07 Melanie Yeoh, Jonathan Erickson, Saumil Desai, Beth Hazeldine, Rebecca Thomas, Craig Gibson, Neil Powers, Nathalie Falkner
IntroductionThere is variability in clinical practice regarding the number of radiographic views required to accurately determine umbilical venous catheter (UVC) tip position. Some units prefer performing a single anteroposterior (AP) view and others do both AP and lateral views. The aim of this study was to compare the need for one versus two radiographical views to accurately determine UVC tip position
-
Long‐term outcomes of definitive radiation with volumetric modulated arc therapy and concurrent chemotherapy for squamous cell carcinoma of the anus in a regional Australian cancer centre J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-07 Michael Ti Hsieh, Thomas Philip Shakespeare, Lauren Winkley, Daniel Goonetilleke, Shaun Zheng Liang Yap, Abdul Rahim Mohd Tahir
IntroductionConcurrent chemoradiotherapy is the standard of care in the curative intent treatment of squamous cell carcinoma (SCC) of the anus. Volumetric arc therapy (VMAT) is a highly conformal radiation therapy technique that has been implemented to reduce toxicity for these patients. However, there are few reports evaluating the long‐term outcomes of VMAT. Thus, we evaluated the survival and toxicity
-
Sutton–Kadir Syndrome can be treated safely with endovascular embolisation alone J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-04 Rama Chidambaram, Julian Soares, Rhiannon Hicks, Shaun Samuelson, Jonathan Tibballs, John Ferguson, Shirley Jansen
IntroductionSutton–Kadir Syndrome (SKS) describes true inferior pancreaticoduodenal artery (IPDA) aneurysms in the setting of coeliac artery (CA) stenosis or occlusion. Although rare, SKS aneurysms can rupture and cause morbidity. Due to its rarity and lack of controlled treatment data, correct treatment for the CA lesion is currently unknown. Our aim was to assess if endovascular embolisation alone
-
Graeme William Morgan AM, B Pharm, MBBS, FRCP(UK), FRANZCR (9th September 1943 – 31st August 2022) J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-04 Kumar Gogna, Michael Back, Margaret Morgan
-
A cost outcome study of varicocoele embolisation and future pregnancy in an Australian public hospital setting J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-04 Warren Clements, Abigail Chenoweth, Laura Morphett, Eliza Billington, Rohan Nandurkar, Tuan Phan, Georgina A Venn, Matthew W Lukies
IntroductionVaricocoele is commonly encountered in males with infertility. Studies have shown that varicocoele repair (surgery or embolisation) can improve the rate of subsequent pregnancy. In Australia, there have been no studies assessing the cost of varicocoele embolisation and current practice is based on international data. This study aimed to assess the cost of varicocoele embolisation and estimate
-
Stability of doxorubicin in radiocontrast medium for use in conventional transarterial chemo‐embolisation procedures J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-03-04 Kennedy Wong, Samuel Davis, Grant Partridge, Brett McWhinney, Nigel Mott, Paul Klages, Roger Bain, Nicholas Cheung
Conflict of interest The authors of this publication do not have any conflict of interests to declare.
-
Towards tumour hypoxia imaging: Incorporating relative oxygen extraction fraction mapping of prostate with multi‐parametric quantitative MRI on a 1.5T MR‐linac J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-02-28 Emmanuel Mesny, Benjamin Leporq, Olivier Chapet, Olivier Beuf
SummaryHypoxia plays a central role in tumour radioresistance. Reliable tumour hypoxia imaging would allow the monitoring of tumour response and a more personalized adaptation of radiotherapy planning. Here, we showed a proof of concept of the feasibility and repeatability of relative oxygen extraction fraction (rOEF) mapping of prostate using multi‐parametric quantitative MRI (qMRI) achieved for the
-
Imaging of supra‐thoracic tuberculosis J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-02-28 Thanat Kanthawang, Nuttaya Pattamapaspong, Nadia Hammami, Mouna Chelli Bouaziz, Mohamed Fethi Ladeb, Pailin Kongmebhol, Wilfred CG Peh
SummaryTuberculosis (TB) typically affects the lungs, but may involve many extra‐pulmonary sites; with the latter especially prone in patients with human immunodeficiency virus infection. The clinical features of extra‐pulmonary TB are often non‐specific, mimicking many different disease entities. Application of the most appropriate imaging modality and knowing the imaging findings with clinical context
-
Accuracy of MRI in predicting deep myometrial invasion in endometrial cancer and the influence of leiomyoma, adenomyosis and the microcystic elongated and fragmented tumour pattern J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-02-20 Anuja Liyanage, Supriya Cardoza, Darshna Kasabia, Helen Moore
IntroductionThe most common form of endometrial cancer is Type 1 endometrioid adenocarcinoma. Depth of myometrial invasion is the most important prognostic factor correlating with overall patient survival. The objective was to investigate how accurate magnetic resonance imaging (MRI) is in predicting the depth of myometrial invasion in preoperative assessment, and the influence of leiomyoma and/or
-
Hearts of stone: Rapidly progressive left ventricular myocardial calcifications in severe sepsis: Case series J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-02-12 Lea Tiffany, Lincoln J Lim
Rapidly progressive left ventricular myocardial calcification (RPLVMC) is a rare phenomenon of severe sepsis which is associated with long-term complications like irreversible cardiomyopathy and arrhythmias. To date, only 19 cases have been reported in literature. We present a case series of two patients with RPLVMC which manifested within a period of days in the setting of severe sepsis. Unique to
-
A retrospective observational study assessing mortality after pelvic trauma embolisation J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-01-31 Warren Clements, Talulla Dunne, Steven Clare, Matthew Lukies, Mark Fitzgerald, Joseph Mathew, Helen Kavnoudias, Adil Zia, Ee Jun Ban, Annabelle Skelley, Jim Koukounaras
Trauma to the pelvic ring and associated haemorrhage represent a management challenge for the multidisciplinary trauma team. In up to 10% of patients, bleeding can be the result of an arterial injury and mortality is reported as high as 89% in this cohort. We aimed to assess the mortality rate after pelvic trauma embolisation and whether earlier embolisation improved mortality.
-
Developing, purchasing, implementing and monitoring AI tools in radiology: Practical considerations. A multi-society statement from the ACR, CAR, ESR, RANZCR & RSNA J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-01-23 Adrian P Brady, Bibb Allen, Jaron Chong, Elmar Kotter, Nina Kottler, John Mongan, Lauren Oakden-Rayner, Daniel Pinto dos Santos, An Tang, Christoph Wald, John Slavotinek
Artificial Intelligence (AI) carries the potential for unprecedented disruption in radiology, with possible positive and negative consequences. The integration of AI in radiology holds the potential to revolutionize healthcare practices by advancing diagnosis, quantification, and management of multiple medical conditions. Nevertheless, the ever-growing availability of AI tools in radiology highlights
-
Assessment of contrast intravasation in patients investigated by fluoroscopic hysterosalpingograms: A two-year retrospective audit in Western Australia J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-01-10 Ci Yue Chia, Emmeline Lee
Intravasation on hysterosalpingogram (HSG) is defined by the flow of injected contrast from the uterine cavity into adjacent myometrial vessels. Evidence suggests intravasation can result in consequences such as pulmonary and cerebral embolisms. However, adverse events are poorly reported across published studies. Reported intravasation ranges from 0.0% to 13%, with higher rates attributed to oil-soluble
-
Curds in the way: A milk curd obstruction review and normal sonographic bowel appearances using a novel scoring system in neonates on fortified breast milk feeds J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-01-07 Lara L Kimble, David Perry, Katinka P Bach
Fortified expressed breast milk (FEBM) is a standard of care for premature and low birth weight neonates, but comes with an elevated risk of a rare but re-emergent pathology called milk curd obstruction (MCO). Little is known about normal sonographic appearances of bowel contents in this feeding setting, making the recognition of abnormalities difficult. Thus, we aimed to describe appearances that
-
Bilateral thalamic high-grade astrocytomas in an early-adolescent child: A case report J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2024-01-07 Dion A Paul, Emma Poon, Mithun Nambiar, Douglas Anderson
An early-adolescent girl presented with incoordination, headache, vomiting and dysphonia. MRI brain demonstrated diffuse increased T2 and FLAIR signal in bilateral thalami, consistent with anaplastic astrocytomas. A stereotactic burr-hole biopsy provided frozen tissues sections demonstrating an IDH-1 wildtype astrocytoma (anaplastic grade III according to prior WHO classification 2016-21). Chemoradiotherapy
-
Guidelines for safe practice of stereotactic body (ablative) radiation therapy: RANZCR 2023 update J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-31 Howard Yu-hao Liu, Nicholas Hardcastle, Michael Bailey, Shankar Siva, Anna Seeley, Tamara Barry, Jeremy Booth, Louis Lao, Michelle Roach, Stacey Buxton, David Thwaites, Matthew Foote
Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
Performance of contrast-enhanced mammography for detecting multifocal and multicentric breast cancer and evaluating tumour size, and implications for surgical management: Early experience in a tertiary centre J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-25 Margaret Thanh Ha Nguyen, Nisha Varma, David Lan Cheong Wah, Renny Chew, Tanita Botha, Susan Kouloyan-Ilic, Joseph Paiva
To compare diagnostic accuracy of contrast-enhanced mammography (CEM) with standard 2D digital mammography (equivalent to low-energy image; LEM) for detection of multifocal and multicentric breast cancer and evaluation of tumour size and disease extent for preoperative planning.
-
Proton beam therapy in paediatric cancer: Anticipating the opening of the Australian Bragg Centre for Proton Therapy and Research J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-25 Jeremy Khong, Hui Tee, Peter Gorayski, Hien Le, Michael Penniment, Sophie Jessop, Jordan Hansford, Melanie Penfold, Julia Green, Kelly Skelton, Frank Saran
Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long-term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir William Henry Bragg who described the Bragg peak in his
-
Reimbursement of interventional oncology in Australia: How it works and how it does not J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-17 Nicholas Brown
The practice of interventional oncology (IO) embodies all the qualities that one would expect to find in a modern, value-based healthcare system. A dynamic, cutting-edge specialty like IO uses highly-targeted, minimally-invasive, image-guided techniques to deliver cost-effective, personalised medicine for cancer patients. Unfortunately, the technical and clinical sophistication of IO is not matched
-
Current applications of algorithmic artificial intelligence in interventional radiology: A review of the literature J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-13 Andrew J O'Brien, John I Vrazas, Warren Clements
Artificial intelligence is a rapidly evolving area of technology whose integration into healthcare delivery infrastructure is predicted to have profound implications for medicine delivery in the 21st century. Artificial intelligence as it relates to healthcare is a term used to cover a wide scope of computer-based algorithms whose application varies from patient selection to enhancements in imaging
-
Thermal ablation of hepatocellular carcinoma J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-14 Laura Crocetti, Paola Scalise, Elena Bozzi, Gianvito Candita, Roberto Cioni
Percutaneous treatment of hepatocellular carcinoma (HCC) by means of thermal ablation (TA) has been introduced in clinical guidelines as a potentially curative treatment for the early stages of the disease since the early 2000s. Due to its safety profile and cost-effectiveness, TA can be offered as a first-line treatment for patients with HCC smaller than 3 cm. Thermal ablative techniques are in fact
-
Efficacy and safety of treating acute haemoptysis using glue embolization: A retrospective observational study and comparison to the literature J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-10 Mohammed Shamseldin, Jörg Kluge, Jens-Uwe Bauer, Ralf Puls
A retrospective observational study of the short-term efficacy and safety of using glue embolization, namely n-butyl-2-cyanoacrylate (NBCA), in bronchial artery embolization (BAE) and comparison with the literature. The main aim of the study is to display the safety of this embolic material through standardization of interventional procedure for consideration of NBCA as a possible primary embolic agent
-
Imaging in interventional oncology, the better you see, the better you treat J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-12-08 Fernando M Gómez, Denise J Van der Reijd, Ilia A Panfilov, Tarik Baetens, Kevin Wiese, Naomi Haverkamp-Begemann, Siu W Lam, Jurgen H Runge, Samuel L Rice, Elisabeth G Klompenhouwer, Monique Maas, Thomas Helmberger, Regina GH Beets-Tan
Imaging and image processing is the fundamental pillar of interventional oncology in which diagnostic, procedure planning, treatment and follow-up are sustained. Knowing all the possibilities that the different image modalities can offer is capital to select the most appropriate and accurate guidance for interventional procedures. Despite there is a wide variability in physicians preferences and availability
-
Comparison of diagnostic accuracy of ultra low-dose computed tomography and X-ray of the kidneys, ureters and bladder for urolithiasis in the follow-up setting J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-24 Mayooran Kandasamy, Michael Chan, Hao Xiang, Lewis Chan, Lloyd Ridley
Urolithiasis is frequently followed up with a low-dose computed tomography of the kidneys ureters and bladder (LD-CTKUB) with doses typically less than 3 millisieverts. Although X-ray is a lower dose (0.5–1.1 mSv) alternative for follow up, it has lower diagnostic accuracy and is limited to radiopaque calculi. This study aims to compare the diagnostic accuracy of sub-millisievert ultra-low dose CT
-
Management and outcomes of glioblastoma: 20-year experience in a single Australian institution J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-24 Bianca Lenffer, Jeremy Ruben, Sashendra Senthi, Jeremy Millar, Wee Loon Ong
We aimed to evaluate the changing patterns in the management of glioblastoma (GBM) and impact on survival outcomes over a 20-year period.
-
Integrated subspecialty training is the best path forward. J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-20 Matthew Lukies
-
Indications for computed tomography angiography in limb trauma J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-20 Wasim Awal, Julia De Groot
Computed tomography angiograms (CTAs) are useful in detecting vascular injury. There is a lack of consensus regarding the indications of CTAs in limb trauma, leading to overutilisation of CTAs in some centres and exposing patients to unnecessary harm. Thus, the aim of this study is to define the appropriate indications for CTAs in limb trauma.
-
Perceptions of work–life balance and gender issues in private radiology in Australia J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-16 Alexa N Seal, Catherine L Hayter, Neha Singh
Women comprise almost 30% of practising clinical radiologists in Australia. Despite three-quarters of clinical radiologists working in private practice, there is limited research regarding the experience of female radiologists in private practice and issues surrounding work–life balance. The primary aim of this study was to identify gender issues within private radiology and investigate work–life balance
-
Neuroimaging manifestations of paediatric histiocytoses J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-14 Hsern Ern Ivan Tan, Rahul Lakshmanan, Richard Warne, Thomas Walwyn, Derek Roebuck
Histiocytoses are rare multi-system disorders marked by abnormal histiocyte cell proliferation, affecting children with diverse clinical presentations. Classified into five groups in 2016, including Langerhans-related (L), cutaneous (C), malignant (M), Rosai–Dorfman disease (R) and haemophagocytic lymphohistiocytosis (H), newer entities such as ALK-positive histiocytosis have also emerged, heralding
-
Radiotherapy in nonagenarian patients: A 20-year retrospective analysis in a single ternary centre J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-14 Atsuto Katano, Hideomi Yamashita
The global burden of cancer and the ageing population is increasing, resulting in an increase in cancer incidence among elderly patients. This study aimed to evaluate the clinical outcomes and safety profile of radiotherapy in nonagenarians and to contribute to the existing knowledge on radiotherapy in elderly patients.
-
Interventional oncology in breast cancer J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-14 Franco Orsi
Breast cancer (BC) is the most common cancer and one of the most important causes of death in women. Surgery is the standard therapy for breast cancer and in the last decades evolved towards a more conservative approach, with lumpectomy, followed by radiation therapy, the most common option. Unfortunately, up to 40% of women affected by BC will develop metastases and will receive systemic therapy,
-
Unseen allies of pain management: Illuminating the crucial role of clinical radiology in pain medicine J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-10 Lincoln J Lim
As the global population ages gracefully, the prevalence of chronic pain arising from degenerative disease, chronic medical conditions, and malignancy will continue to rise. It is estimated that 17% of the world population will be above the age of 60 years by 2030. By 2050, 2.1 billion of the global population will be 60 years and above, and 426 million will be 80 years and above.1 Our already strained
-
Percutaneous image-guided ablation for hepatic metastases J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-11-09 Vlasios S Sotirchos, Elena N Petre, Constantinos T Sofocleous
The presence of hepatic metastases indicates advanced disease and is associated with significant morbidity and mortality, especially when the hepatic disease is not amenable to locoregional treatments. The primary tumour of origin, the distribution and extent of metastatic disease, the underlying liver reserve, the patient performance status and the presence of comorbidities are factors that determine
-
Palliative radiotherapy is effective for both well- and poorly differentiated neuroendocrine neoplasms J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-29 Eileen O'Reilly, Louis Lao, Braden Woodhouse, Katrina Sharples, Cris Print, Ben Lawrence
The outcomes of palliative radiation therapy (RT) for neuroendocrine neoplasms (NEN) are seldom reported. We investigated outcomes following palliative radiotherapy in a cohort of patients with NENs. We hypothesised that well-differentiated NEN will be less likely to have a clinical response than poorly differentiated NEN.
-
The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy – A prospective cohort study J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-29 Isaac J May, Anna K Nowak, Roslyn J Francis, Martin A Ebert, Satvinder S Dhaliwal
Malignant pleural mesothelioma is difficult to prognosticate. F18-Fluorodeoxyglucose positron emission tomography (FDG PET) shows promise for response assessment but is confounded by talc pleurodesis. F18-Fluorothymidine (FLT) PET is an alternative tracer specific for proliferation. We compared the prognostic value of FDG and FLT PET and determined the influence of talc pleurodesis on these parameters
-
Cystic lung disease in adult Indigenous Australians in the Northern Territory of Australia J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-16 Kritika Mishra, Rumana Fazal, Timothy Howarth, John Mutai, Arockia X Doss, Subash S Heraganahally
Indigenous Australians have a high prevalence of chronic lung diseases. However, no previous studies have reported on cystic lung disease in an Indigenous patient cohort.
-
Acknowledgements J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-11
The College would like to acknowledge the contributions made by the Organising Committee to the 73rd Annual Scientific Meeting. In addition, the tireless efforts of reviewers and presenters who provide their time and expertise to develop the quality educational program content at the ASM.
-
Clinical Radiology Orals J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-11
Women's 1, Thursday October 19 2023, 11:00–12:30
-
Clinical Radiology Exhibits J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-11
Medical students' perceptions of radiology education and attitudes towards radiology A Abar Griffith University, Gold Coast, Queensland, Australia Purpose: Medical education transformed immensely in the past decade and has more recently become increasingly digitized. These changes have been accelerated by COVID-19. However, throughout this modernisation, it is suggested that there is a continued paucity
-
Radiation Oncology Exhibits J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-11
Cohort results of 4Gy radiotherapy in low-grade lymphoma patients: a retrospective audit A Armstrong, G Metz and S Carrol Northern Sydney Cancer Centre, St Leonards, New South Wales, Australia Purpose: To evaluate the efficacy of 4Gy in 2 fractions (#) for the treatment of low-grade lymphoma patients and assess if gross tumour volume (GTV) size impacts outcomes. Methods and Materials: 58 consecutive
-
Radiation Oncology Orals J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-11
GI, Thursday, October 19, 2023, 11:00–12:30
-
Population-based patient-reported quality of life outcomes following low-dose-rate versus high-dose-rate brachytherapy monotherapy for low-intermediate risk prostate cancer J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-12 Wee Loon Ong, Melanie Evans, Nathan Papa, Scott Williams, Jeremy Millar
To evaluate patient reported quality of life outcomes (QoL) following low-dose-rate brachytherapy (LDR-BT) and high-dose-rate brachytherapy (HDR-BT) monotherapy for prostate cancer at a population-based setting.
-
Transcatheter arterial embolisation for the relief of shoulder and elbow chronic joint pain refractory to conventional treatment: Systematic review J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-09 Mohamed Aly, Chelsea Fashina, Ahmed Hagiga, Ahmed Hafez, Livio Di Mascio
Angiogenesis and accompanying nerve fibres might cause unsettling joint pain. Studies have suggested that transcatheter arterial embolisation (TAE) of these abnormal neovessels could relieve pain and symptoms in patients with upper limb joint pain refractory to conventional treatment. This study aims to investigate the efficacy and safety of TAE in treating chronic pain of shoulder and elbow joints
-
Incidental finding of tall cell variant papillary thyroid carcinoma on prostate-specific membrane antigen PET CT scan J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-05 Benjamin Xie, Christopher Lehane, Felik Paulus, Ivan Ho Shon
Prostate-specific membrane antigen (PSMA) PET CT is widely used for staging and restaging of prostate cancer. Thyroid and other non-prostatic pathology may be incidentally identified by this imaging modality. Such findings warrant further investigation given their malignant potential. We describe the first reported case of PSMA avid T cell-variant papillary thyroid carcinoma incidentally detected on
-
Rising use of diagnostic imaging in Australia: An analysis of Medicare-funded radiology services between 2000 and 2021 J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-10-05 Patrick Lu, Mustafa Mian, Matthew Yii, David John Tobias McArdle, Alexander Rhodes, Subhashaan Sreedharan
The use of diagnostic imaging services is increasing worldwide. This has important impacts on healthcare resource allocation and potential risks to the population. This study aimed to quantify trends in medical imaging in Australia over the past two decades.
-
Evaluation of facial nerve perineural spread from cutaneous squamous cell carcinoma using 3T MR neurography J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-24 Michael JC Schachtel, Benedict J Panizza, Mitesh Gandhi
Perineural spread (PNS) is a rare but potentially fatal consequence of cutaneous squamous cell carcinoma (cSCC) of the head and neck. We aimed to evaluate the accuracy of 3T MR neurography in detecting and defining the extent of facial nerve (VII) PNS from cSCC, and highlight characteristic radiological features in peripheral branches to improve early diagnosis.
-
Development and implementation barriers of a new patient-reported measure: The Radiation therapy-related Inconvenience Questionnaire (RIQ) J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-24 Chindhu Shunmugasundaram, Puma Sundaresan, Kate White, Madeleine T King, Chris Milross, Lucinda Rodd, Matthew Fuller, Claudia Rutherford
Radiation therapy (RT) can benefit approximately 50% of cancer patients and contribute to 40% of all cancer cures, yet its utilisation in cancer is low globally. Several factors contribute to this including perceived inconvenience related to accessing and utilising RT. To quantitatively assess the latter, a new tool – the Radiation therapy-related Inconvenience Questionnaire (RIQ) – was developed.
-
Interventional management of malignant bone tumours J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-24 Roberto Luigi Cazzato, Julien Garnon, Jack William Jennings, Afshin Gangi
In the last few decades, interventional radiology (IR) has significantly increased its role in the management of bone tumours including bone metastases (BM) that represent the most common type of tumour involving the bone. The current IR management of BM is based on the ‘palliative-curative’ paradigm and relies on the use of consolidative (i.e. osteplasty, osteosynthesis) and/or ablation (i.e. cryoablation
-
The percutaneous management of pulmonary metastases J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-24 Thierry de Baere, Baptiste Bonnet, Lambros Tselikas, Frederic Deschamps
Local treatment of lung metastases has been in the front scene since late 90s when an international registry of thoracic surgery reported a median overall survival of 35 months in resected patients versus 15 months in non-resected patients. Today, other local therapies are available for patients with oligometastatic lung disease, including image guided thermal ablation, such as ablation, microwave
-
Deep learning to predict lymph node status on pre-operative staging CT in patients with colon cancer J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-19 Sergei Bedrikovetski, Jianpeng Zhang, Warren Seow, Luke Traeger, James W Moore, Johan Verjans, Gustavo Carneiro, Tarik Sammour
Lymph node (LN) metastases are an important determinant of survival in patients with colon cancer, but remain difficult to accurately diagnose on preoperative imaging. This study aimed to develop and evaluate a deep learning model to predict LN status on preoperative staging CT.
-
The where, who and how of adrenal vein sampling in Australia and New Zealand J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-11 Elisabeth Ng, Winston Chong, Kenneth K Lau, Stella May Gwini, Richard W Carroll, James CG Doery, Peter J Fuller, Jun Yang
Primary aldosteronism (PA) causes 10–15% of cases of hypertension, and it is increasingly recognised as being under-diagnosed. An interventional radiology procedure, adrenal vein sampling (AVS), is a necessary and important diagnostic procedure for complete workup of PA. There is an anticipated increase in demand for AVS as detection of PA improves. This study aims to describe the current landscape
-
Where does the gadolinium go? A review into the excretion and retention of intravenous gadolinium J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-09-04 Pranav Sharma, Jeffrey Cheng, Alan Coulthard
Gadolinium-based contrast agents (GBCAs) are commonly used in medical imaging. Most intravenously (IV) administered gadolinium is excreted via the kidneys, and pathological retention in renal failure leading to nephrogenic systemic fibrosis (NSF) is well described. More recently, retention of gadolinium in the body in the absence of renal disease has been identified, with unknown clinical consequences
-
Hip dysplasia hiding in plain sight: A retrospective analysis of radiology reports J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-08-31 Rebecca M Woodward, Nicholas J Lightfoot, Renuka M Vesey, Stephanie A van Dijck, Jacob T Munro, Matthew J Boyle
Timely recognition of dysplastic hip morphology is critical to facilitate appropriate management before significant joint damage has developed. It is likely that radiologist under reporting contributes to delays in diagnosis. This study aimed to assess how often adult hip dysplasia goes undetected in radiological reports and to identify clinical and radiological variables that impact the likelihood
-
Sharing images on social media without patient consent J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-08-31 George Rahmani
The purpose of this article is to initiate a discussion around the growing trend of sharing images of patients' scans without their consent on social media. While there are certainly merits in sharing images on social media, if undertaken without due care, it has the potential to be unprofessional and harmful to both patients and the radiology profession. In this article, I will outline some of the
-
Endovascular repair combined with in situ fenestration for new-onset or residual arch dissection in patients underwent aortic replacement J. Med. Imaging Radiat. Oncol. (IF 1.6) Pub Date : 2023-08-31 Zhexin Lu, Jin Huang, Yongliang Fan, Hongbing Gu, Xian Zhu, Min Yu, Yizhou Ye
Ascending aorta or hemi-arch replacement is a frequently used treatment for patients with acute type A thoracic aortic dissection, particularly those who are elderly or have multiple comorbidities. However, in cases where there are secondary entry tears in the aortic arch or descending aorta, this procedure may not fully resolve the issue. The true lumen may remain compressed due to perfusion of the